J B Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.30 Cr
- Paid Up Capital ₹ 15.54 Cr
- Company Age 48 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 445.76 Cr
- Satisfied Charges ₹ 370.14 Cr
- Revenue Growth 15.23%
- Profit Growth 39.72%
- Ebitda 32.30%
- Net Worth 18.17%
- Total Assets 12.78%
About J B Chemicals And Pharmaceuticals
J B Chemicals And Pharmaceuticals Limited (JBCAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 December 1976 and has a history of 48 years and one month. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506943 and on the National Stock Exchange(NSE) under JBCHEPHARM.
The Corporate was formerly known as J B Chemicals And Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.30 Cr and a paid-up capital of Rs 15.54 Cr.
The company currently has active open charges totaling ₹445.76 Cr. The company has closed loans amounting to ₹370.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at J B Chemicals And Pharmaceuticals Limited India are Sandeep Phadnis as Company Secretary, Nikhil Chopra as Ceo, and Narayan Saraf as Cfo. Arun Duggal, Padmini Khare, Akshay Tanna, and Four other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24390MH1976PLC019380
- Company No.
019380
- Stock Symbol
BSE : 506943 NSE : JBCHEPHARM
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Dec 1976
- Date of AGM
21 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does J B Chemicals And Pharmaceuticals Limited offer?
J B Chemicals And Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Flavours & Aromatics, Food Preservative, Anti Infective API, Animal Medicines & Health Care, Anthelmintics, Anti Inflammatory and Immunosuppressant API.
Who are the key members and board of directors at J B Chemicals And Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Phadnis  | Company Secretary | 15-Jul-2021 | Current |
| Nikhil Chopra | CEO | 23-Dec-2020 | Current |
| Narayan Saraf | CFO | 22-Mar-2024 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Bose | Director | 31-Aug-2020 | Current |
Arun Duggal  | Director | 05-Jul-2024 | Current |
| Akshay Tanna | Director | 07-Nov-2023 | Current |
| Padmini Khare | Director | 31-Aug-2020 | Current |
| Gaurav Trehan | Director | 10-Feb-2021 | Current |
| Nikhil Chopra | Whole-Time Director | 05-Oct-2020 | Current |
Financial Performance of J B Chemicals And Pharmaceuticals.
J B Chemicals And Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.23% increase. The company also saw a substantial improvement in profitability, with a 39.72% increase in profit. The company's net worth Soared by an impressive increase of 18.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J B Chemicals And Pharmaceuticals?
In 2024, J B Chemicals And Pharmaceuticals had a promoter holding of 53.78% and a public holding of 46.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vini Cosmetics Private LimitedAkshay Tanna is a mutual person
Infinx Services Private LimitedAkshay Tanna is a mutual person
Healthium Medtech LimitedAkshay Tanna is a mutual person
Ask Automotive LimitedArun Duggal is a mutual person
Kotak Mahindra Investments LimitedPadmini Khare is a mutual person
Jm Financial LimitedSumit Bose is a mutual person
Charges (Loans)
₹445.76 Cr
₹370.14 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 300.00 Cr
- State Bank Of India : 75.00 Cr
- Bank Of India : 70.00 Cr
- Laxmichand Bhagaji : 0.55 Cr
- Dena Bank : 0.17 Cr
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2023 | State Bank Of India | ₹75.00 Cr | Open |
| 28 Jun 2022 | Axis Bank Limited | ₹300.00 Cr | Open |
| 22 Oct 1997 | Bank Of India | ₹38.00 Cr | Open |
| 07 May 1997 | Dena Bank | ₹1.00 M | Open |
| 04 Mar 1997 | Bank Of India | ₹32.00 Cr | Open |
How Many Employees Work at J B Chemicals And Pharmaceuticals?
J B Chemicals And Pharmaceuticals has a workforce of 5984 employees as of Nov 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J B Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J B Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
